|
AML, CCAAT/Enhancer Binding Protein Alpha Monoallelic Gene Mutation
|
100412 |
|
|
AML, CCAAT/Enhancer Binding Protein, Alpha Biallelic Gene Mutation
|
100413 |
|
|
AML, CCAAT/Enhancer Binding Protein, Alpha Gene Mutation
|
100414 |
|
|
AML, CCAAT/Enhancer Binding Protein, Alpha Monoallelic Gene Mutation
|
100412 |
|
|
AML, monoallelic CEBPA gene mutation
|
100412 |
|
|
AML, biallelic CEBPA gene mutation
|
100413 |
|
|
spastic ataxia Charlevoix-Saguenay type
|
10041 |
|
|
spastic ataxia, Charlevoix-Saguenay type
|
10041 |
|
|
spastic ataxia, Charlevoix-Saguenay type; sacs
|
http://purl.obolibrary.org/obo/MONDO_0010041 |
|
|
spastic ataxia 6, autosomal recessive
|
10041 |
|
|
AML, CCAAT Enhancer Binding Protein Alpha Gene Mutation
|
100414 |
|
|
AML, CCAAT Enhancer Binding Protein Alpha Monoallelic Gene Mutation
|
100412 |
|
|
AML, CD117 Exon 17 Mutation
|
100418 |
|
|
AML, c-KIT Exon 17 Mutation
|
100418 |
|
|
AML, CD117 Exon 8 Mutation
|
100419 |
|
